117 related articles for article (PubMed ID: 29532873)
1. COMMD7 activates CXCL10 production by regulating NF-κB and the production of reactive oxygen species.
You N; Li J; Huang X; Wu K; Tang Y; Wang L; Li H; Mi N; Zheng L
Mol Med Rep; 2018 May; 17(5):6784-6788. PubMed ID: 29532873
[TBL] [Abstract][Full Text] [Related]
2. COMMD7 promotes hepatocellular carcinoma through regulating CXCL10.
You N; Li J; Huang X; Wu K; Tang Y; Wang L; Li H; Mi N; Zheng L
Biomed Pharmacother; 2017 Apr; 88():653-657. PubMed ID: 28142122
[TBL] [Abstract][Full Text] [Related]
3. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.
Zheng L; Deng CL; Wang L; Huang XB; You N; Tang YC; Wu K; Liang P; Mi N; Li J
Oncotarget; 2016 May; 7(22):32774-84. PubMed ID: 27129158
[TBL] [Abstract][Full Text] [Related]
4. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
5. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
7. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
8. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
9. RBM23 Drives Hepatocellular Carcinoma by Activating NF-
Han H; Lin T; Fang Z; Zhou G
Biomed Res Int; 2021; 2021():6697476. PubMed ID: 33791378
[TBL] [Abstract][Full Text] [Related]
10. TNF-α mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-κB activation in liver cells.
Kastl L; Sauer SW; Ruppert T; Beissbarth T; Becker MS; Süss D; Krammer PH; Gülow K
FEBS Lett; 2014 Jan; 588(1):175-83. PubMed ID: 24316229
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
[TBL] [Abstract][Full Text] [Related]
12. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
13. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
14. Koumine Promotes ROS Production to Suppress Hepatocellular Carcinoma Cell Proliferation Via NF-κB and ERK/p38 MAPK Signaling.
Yuan Z; Liang Z; Yi J; Chen X; Li R; Wu J; Sun Z
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581704
[TBL] [Abstract][Full Text] [Related]
15. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
[TBL] [Abstract][Full Text] [Related]
17. ZNF460-regulated COMMD7 Promotes Acute Myeloid Leukemia Proliferation Via the NF-κB Signaling Pathway.
Shao X; Zhong L; Chu X; Wan P; Chen S; Zhou Z; Zhang H; Wang M; Liu B
Int J Med Sci; 2023; 20(4):520-529. PubMed ID: 37057209
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells.
Huang Q; Cao H; Zhan L; Sun X; Wang G; Li J; Guo X; Ren T; Wang Z; Lyu Y; Liu B; An J; Xing J
Cancer Lett; 2017 Sep; 403():108-118. PubMed ID: 28624623
[TBL] [Abstract][Full Text] [Related]
20. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
